{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpolitico-audio-feed.simplecast.com%2Fepisodes%2Ffda-facing-critical-decision-paMwL5gd","width":444,"version":"1.0","type":"rich","title":"FDA facing critical decision","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/c19de819-931e-4d07-823c-6cc5df3ecb2f/193b35b5-e3db-4f9f-9786-4f61106466d2/politico-logo-33.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/17b12aea-b26e-44e2-92e0-5eea7005ceb6\" height=\"200\" width=\"100%\" title=\"FDA facing critical decision\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"The FDA will decide whether to uphold, revise or scrap longstanding restrictions on the abortion drug mifepristone. This decision will likely kick off the next chapter in the abortion wars."}